Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
November 24, 2019 | POZ
The World Cannot End HIV Without Continued Innovation
POZ looks at diversifying the HIV prevention toolkit, including with microbicides. More »
November 10, 2019 | Health Policy Watch
Bringing Health Innovations To Market Is Key In The Global Fight Against HIV/AIDS, Malaria And Tuberculosis
A side event ahead of the Global Fund’s Sixth Replenishment Conference. co-sponsored by IPM, highlighted the role of PDPs in advancing global health innovation. More »
September 02, 2019 | Medscape (France)
La PrEP s’étoffe avec un implant sous-cutané et un anneau vaginal à libération prolongée d'ART
Results from the HOPE study of the dapivirine vaginal ring were presented at IAS 2019. More »
August 06, 2019 | Healio
HOPE trial: Dapivirine vaginal ring reduces HIV risk by estimated 39%
“The more options that are developed and used, the better chance we have to turn the tide on the global HIV epidemic,” Baeten said. More »
July 29, 2019 | HIV Plus Magazine
Vaginal Ring Brings New Hope For HIV Prevention in Women
The HOPE study shows high levels of adherence and effectiveness for a new kind of PrEP for women. More »